GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
3

3-D Matrix 7777.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

295

-0.34%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥10.89bn

FY2017FY2026

Net income

¥4.16bn

FY2017FY2026

Free cash flow

¥368.9m

FY2017FY2026

Shareholders' equity

¥6.80bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥10.89bn¥6.93bn¥4.59bn¥2.31bn¥1.51bn¥1.02bn¥672.4m¥328.8m¥228.6m¥615.9m
Research and development¥640.2m¥498.2m¥555.6m¥451.5m¥684.5m¥785.4m¥801.5m¥786.1m¥562.3m¥469.5m
Operating income¥1.36bn−¥2.39bn−¥2.06bn−¥3.16bn−¥2.74bn−¥2.65bn−¥3.10bn−¥2.55bn−¥1.87bn−¥1.49bn
Net income¥4.16bn−¥2.50bn−¥255.5m−¥2.45bn−¥1.89bn−¥2.01bn−¥3.10bn−¥2.55bn−¥1.87bn−¥1.39bn
Diluted earnings per share31.00-19.85-2.56-34.62-31.83-37.01-84.65-89.28-77.76-63.86

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥9.80bn¥6.51bn¥5.89bn¥5.83bn¥5.61bn¥3.51bn¥3.12bn¥4.09bn¥3.14bn¥3.42bn
Cash and short-term investments¥2.83bn¥1.58bn¥1.36bn¥1.17bn¥2.85bn¥1.14bn¥1.06bn¥1.80bn¥1.16bn¥1.75bn
Total liabilities¥3.00bn¥4.30bn¥5.53bn¥5.30bn¥4.15bn¥1.85bn¥2.64bn¥2.58bn¥933.9m¥816.3m
Debt¥600.0m¥2.94bn¥4.17bn¥4.37bn¥3.67bn¥1.46bn¥1.80bn¥1.85bn¥450.0m¥450.0m
Shareholders' equity¥6.80bn¥2.22bn¥353.3m¥524.8m¥1.46bn¥1.66bn¥473.0m¥1.51bn¥2.20bn¥2.61bn
Shares outstanding134m126m100m71m60m54m37m29m24m22m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥396.8m−¥1.71bn−¥1.90bn−¥4.59bn−¥2.90bn−¥3.25bn−¥2.19bn−¥2.30bn−¥2.02bn−¥1.89bn
Capital spending−¥28.0m−¥12.3m−¥4.3m−¥18.7m−¥13.1m−¥25.8m−¥18.3m−¥26.4m−¥27.9m−¥23.0m
Free cash flow¥368.9m−¥1.73bn−¥1.90bn−¥4.60bn−¥2.92bn−¥3.28bn−¥2.21bn−¥2.33bn−¥2.05bn−¥1.91bn
Dividends paid——————−¥12.0m−¥1.37bn——

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue¥3.23bn¥3.54bn¥2.54bn¥2.61bn¥2.19bn¥1.87bn¥1.79bn¥1.79bn
Operating income¥494.7m¥628.4m¥346.6m¥351.2m¥9.0m−¥550.2m−¥74.1m−¥215.0m
Net income¥303.0m¥1.80bn¥652.4m¥936.4m¥765.0m−¥1.11bn−¥588.0m−¥18.0m
Diluted earnings per share2.2613.444.877.436.07-8.79-4.67-0.18
Total assets¥9.40bn¥9.80bn¥7.57bn¥6.80bn¥6.37bn¥6.51bn¥7.04bn¥6.70bn
Cash and short-term investments¥1.69bn¥2.83bn¥2.10bn¥1.58bn¥1.49bn¥1.58bn¥1.98bn¥2.07bn
Debt¥600.0m¥600.0m¥300.0m¥1.40bn¥300.0m¥2.94bn¥300.0m¥300.0m
Shareholders' equity¥7.22bn¥6.80bn¥5.18bn¥3.95bn¥2.69bn¥2.22bn¥2.64bn¥1.81bn

Financial ratios

Data as of 15 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin12.5%-34.5%-44.8%-136.5%-181.7%-258.6%
Net margin38.2%-36.1%-5.6%-105.7%-125.8%-196.5%
Return on equity61.1%-112.9%-72.3%-466.1%-130.0%-121.3%
Return on assets42.4%-38.4%-4.3%-42.0%-33.8%-57.4%
Free cash flow yield0.8%-3.4%-4.8%-16.4%-12.4%-15.1%
Revenue growth57.0%51.1%98.3%53.6%47.0%52.3%
Earnings growth-266.2%878.9%-89.6%29.1%-5.9%-35.0%
Current ratio3.11x4.07x3.77x4.35x6.43x4.49x
Debt to equity0.09x1.33x11.81x8.33x2.51x0.88x
Equity ratio69.4%34.0%6.0%9.0%26.0%47.3%
Interest coverage75.63x-32.16x-24.57x-52.15x-572.52x-566.19x
R&D as a share of sales5.9%7.2%12.1%19.5%45.4%76.7%
Buybacks as a share of market value-6.4%-26.5%-41.0%-18.7%-9.5%-48.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue67.6%60.4%54.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-5.8%-25.3%-42.7%-76.8%
Net margin9.3%-4.2%-18.2%-55.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings10.4-18.1-64.3-4.0-9.7-14.2-3.4-5.3-4.4-12.5
Price to sales4.06.53.64.312.227.815.741.636.128.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 29 May 2013
  • 2-for-1 split · 29 Aug 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.